Evolution of Biologics in Inflammatory Medicine

Biosimilars Congress 2019 is included Keynote and Speakers sessions on the most recent examination intended to offer extensive worldwide exchanges that address current issues in Biosimilars Congress 2019

The treatment of ceaseless incendiary maladies in grown-ups and kids with focused biotechnologically designed proteins (eg antibodies to cytokines, for example, hostile to Tumor Necrosis Factor [TNF] - ?, against CD20 antibodies or combination proteins) Treatment alternatives for constant fiery sicknesses in gastroenterology, rheumatology and dermatology

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you